Immix Biopharma Inc

IMMX.US
Healthcare · Biotechnology
8.44
-0.25 (-2.88%)
USD · NASDAQ

Company Information

▼
Company Name
Immix Biopharma Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45258H1068
CIK: 0001873835
CUSIP: 45258H106
Currency: USD
Full Time Employees: 21
Phone: 310 651 8041
Website: https://www.immixbio.com
Fiscal Year End: December
IPO Date: Dec 16, 2021
Description:

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

Address:

11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064

People

▼

Directors & Officers

Name Title Year Born
Dr. Ilya Rachman M.B.A., M.D., Ph.D. Co-Founder, CEO, Chief Scientific Officer & Chairman 1973
Mr. Gabriel Morris B.A. President, CFO & Director 1987
Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D. Scientific Co-Founder 1947
Dr. Graham Ross FFPM, M.D. Chief Medical Officer & Head of Clinical Development 1960
Dr. David Marks MBBS, Ph.D. Chief Medical Officer of Cell Therapy NA
Mr. Mel Davis-Pickett Head of CMC Technical Development NA
Mr. Michael A. Grabow Chief Commercial Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 10, 2025 Gabriel S Morris N/A Purchase 770.00 $6.58 $5.07K
Dec 10, 2025 Ilya M Rachman N/A Purchase 746.00 $6.67 $4.98K
Sep 17, 2025 Ilya M Rachman N/A Purchase 2.50K $2.02 $5.05K
Sep 16, 2025 Gabriel S Morris N/A Purchase 2.60K $1.97 $5.12K
Jun 18, 2025 Gabriel S Morris N/A Purchase 2.23K $2.28 $5.07K
Jun 18, 2025 Ilya M Rachman N/A Purchase 2.18K $2.29 $4.99K

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
HHG PLC 4.80M Mar 31, 2026 6.75% $0.02 22.45%
Saturn V Capital Management LLC 3.69M Mar 31, 2026 5.19% $6.09 23.15%
Eventide Asset Management, LLC 2.55M Mar 31, 2026 3.58% $0.38 0.00%
Vanguard Capital Management, LLC 1.79M Mar 31, 2026 2.51% $0.00 0.00%
Millennium Management LLC 1.75M Mar 31, 2026 2.46% $0.01 5.45%
Marshall Wace Asset Management Ltd 1.64M Mar 31, 2026 2.31% $0.01 -17.04%
Logos Global Management LP 1.23M Mar 31, 2026 1.72% $0.56 22.50%
Vanguard Group Inc 1.10M Dec 31, 2025 1.54% $0.00 50.08%
Bleichroeder LP 1.00M Mar 31, 2026 1.40% $1.57 0.00%
Franklin Resources Inc 969.07K Mar 31, 2026 1.36% $0.00 -1.16%
Velan Capital Investment Management LP 740.00K Mar 31, 2026 1.04% $4.22 2,014.29%
Blue Owl Capital Holdings LP 547.55K Mar 31, 2026 0.77% $1.34 -44.48%
Susquehanna International Group, LLP 471.39K Mar 31, 2026 0.66% $0.00 19.68%
BlackRock Inc 468.38K Mar 31, 2026 0.66% $0.00 259.58%
Geode Capital Management, LLC 463.38K Mar 31, 2026 0.65% $0.00 88.32%
LGT Fund Management Company Ltd 416.59K Mar 31, 2026 0.59% $0.16 233.28%
T. Rowe Price Associates, Inc. 415.00K Mar 31, 2026 0.58% $0.00 0.00%
Great Point Partners LLC 350.00K Mar 31, 2026 0.49% $0.73 0.00%
Institute for Wealth Management, LLC 337.55K Mar 31, 2026 0.47% $0.33 0.00%
Burkehill Global Management, LP 294.12K Mar 31, 2026 0.41% $0.13 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Eventide Healthcare & Life Sciences I 2.55M 3.58% ▲ 0.00% Mar 31, 2026
2 State Street® SPDR® S&P® Biotech ETF 2.10M 2.94% ▼ 2.18% Jun 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.78M 2.50% ▲ 38.50% Jun 30, 2026
4 iShares Russell 2000 ETF 1.07M 1.51% ▲ 0.60% Jun 30, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 681.21K 0.96% ▲ 4.02% Jun 30, 2026
6 Franklin Biotechnology Discv A(acc)USD 612.03K 0.86% ▲ 0.00% Jun 30, 2026
7 Columbia Small Cap Growth 447.64K 0.63% ▲ 0.00% Jun 30, 2026
8 HR SICAV - Global Quant Equits - (GBP) A 416.59K 0.59% ▲ 0.00% Jun 30, 2026
9 iShares Russell 2000 Growth ETF 369.28K 0.52% ▼ 0.38% Jun 30, 2026
10 Franklin Biotechnology Discovery A 357.03K 0.50% ▲ 0.00% Jun 30, 2026

Financial Highlights

▼
Market Cap: $618.64M
EBITDA: $-35.78M
Book Value: $1.59
Earnings/Share: $-0.94
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.97%
ROE (TTM): -74.46%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $529.10M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 71.19M
Shares Float: 43.40M
% Insiders: 1,756.00%
% Institutions: 4,579.00%
Short % Float: 14.44%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-364.50K
Gross Profit
subtotal
$-364.50K
SG&A
adjust
$-13.70M
R&D
adjust
$-16.26M
Operating Income
subtotal
$-27.21M
Other / Non-Operating Items
adjust
$-2.23M
Net Income
subtotal
$-29.44M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMMX.US!